[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366728-105":59,"doc-detail-366728-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","all-trans-retinal-as-a-modulator-of-metabolic-and-mitochondrial-signatures-in-non-tumorigenic-and-malignant-breast-cells-a-raman-based-approach","All-trans-retinal as a modulator of metabolic and mitochondrial signatures in non-tumorigenic and malignant breast cells - a Ramanbased approach","","Retinoids are recognized for therapeutic potential, yet the specific effects of all-trans-retinal (ALTR) on breast cancer cell metabolism—especially regarding dose, incubation time, and tumor aggressiveness—remain insufficiently clarified. This study evaluates ALTR effects on non-tumorigenic MCF10A and malignant MCF7 and MDA-MB-231 cells using Raman imaging plus XTT viability assays. Cells were treated with 1 and 10 µM ALTR for 24 and 48 h. Raman spectroscopy tracked subcellular metabolic changes and showed reduced viability in cancer lines and enhanced developmental signals in MCF10A, including ALTR-related redox modulation of mitochondrial cytochrome c, with strongest effects in non-tumorigenic cells. Results support Raman tools for phenotyping and metabolic assessment and suggest ALTR as a breast cancer therapy candidate.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/all-trans-retinal-as-a-modulator-of-metabolic-and-mitochondrial-signatures-in-non-tumorigenic-and-malignant-breast-cells-a-raman-based-approach/366728/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/all-trans-retinal-as-a-modulator-of-metabolic-and-mitochondrial-signatures-in-non-tumorigenic-and-malignant-breast-cells-a-raman-based-approach/366728.png","ImageObject",300,407,{"name":92,"@type":93},"Anna Hans","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What gap in knowledge does the study address about all-trans-retinal (ALTR) in breast cells?","Question",{"text":113,"@type":114},"The work targets insufficient understanding of ALTR’s specific effects on breast cancer cell metabolism, particularly how dose and incubation time relate to tumor aggressiveness.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which cell lines and experimental conditions were used to test ALTR?",{"text":118,"@type":114},"Non-tumorigenic MCF10A and malignant MCF7 and MDA-MB-231 cells were incubated with 1 and 10 µM ALTR for 24 and 48 hours.",{"name":120,"@type":111,"acceptedAnswer":121},"How did the researchers assess metabolic and mitochondrial changes after ALTR treatment?",{"text":122,"@type":114},"Raman spectroscopy and imaging were used to detect qualitative and quantitative subcellular changes, while XTT assays measured biological viability; mitochondrial redox changes were inferred from cytochrome c band intensity changes.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},366728,1790200360,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909892332657,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Microchimica Acta (2025) 192:725  \n[https://doi.org/10.1007/s00604-025-07571-6](https://doi.org/10.1007/s00604-025-07571-6)  \nAll-trans-retinal as a modulator of metabolic and mitochondrial signatures in non-tumorigenic and malignant breast cells: a Ramanbased approach  \nKarolina Jarczewska1 · Monika Kopeć1 · Jakub Maciej Surmacki1  \nReceived: 1 August 2025 / Accepted: 11 September 2025 / Published online: 11 October 2025 © The Author(s) 2025  \nAbstract  \nRetinoids are well recognized for their therapeutic potential in pharmacy and medicine. Although extensively studied for their anticancer properties, the specific effects of all-trans-retinal (ALTR) on the metabolism of breast cancer cells—particularly in relation to dose, incubation time, and tumour aggressiveness—remain insufficiently understood. In this study, the metabolic impact of ALTR on non-tumorigenic (MCF10A) and malignant breast cell lines (MCF7, MDA-MB-231) using Raman imaging and biological viability assays (XTT) were examined. Cells were incubated with 1 and 10 µM concentrations of ALTR for 24 and 48 h. Raman spectroscopy and imaging enabled both qualitative and quantitative detection of cellular organelles, allowing us to track ALTR-associated metabolic changes at the subcellular level. Our findings demonstrate that ALTR significantly reduced cell viability, particularly in cancerous lines, while promoting cellular development in non-tumorigenic MCF10A cells. Notably, a Raman band at 1597 cm−1 appeared in MCF10A cells following ALTR treatment, potentially indicating metabolic conversion of ALTR into esterified forms. Furthermore, ALTR supplementation modulated the redox state of mitochondrial cytochrome c, as reflected by intensity changes in the 1583 cm−1 band corresponding to its reduced form. These effects were most prominent in non-tumorigenic cells, suggesting enhanced sensitivity to ALTR-induced redox alterations. Collectively, our results highlight the value of Raman spectroscopy and imaging as powerful tools for cancer cell phenotyping and metabolic assessment. The observed inhibition of cancer cell proliferation, combined with alterationsin mitochondrial redox balance, positions ALTR as a promising candidate for breast cancer therapy.  \nKeywords Breast cancer · Cancer cell phenotyping · All-trans-retinal · Raman spectroscopy · Raman imaging  \nIntroduction  \nIn the human diet, retinoids are predominantly derived either as preformed vitamin A (retinol and its esters) from animalbased sources or as provitamin A carotenoids from plantbased foods. Significant amounts of preformed retinoids are found in dairy products, fish, meat, and especially in animal liver [1–3] . They are stored in the liver in stellate cells [1] . Their common chemical structure element is four isoprene units linked in a tail-head structure [4] . Most retinoids contain a cyclic end group, a polyene side chain, and a polar end  \n* Jakub Maciej Surmacki [jakub.surmacki@p.lodz.pl](jakub.surmacki@p.lodz.pl)  \n1 Laboratory of Laser Molecular Spectroscopy, Institute of Applied Radiation Chemistry, Faculty of Chemistry, Lodz University of Technology, Wroblewskiego 15, 93-590 Lodz, Poland  \ngroup [5] . Currently, retinoids are considered to be compounds that bind and activate nuclear receptors, leading to the transcription of specific genes [6] . Retinoids’ functions include immune response, reproduction, vision, cellular communication, and differentiation [7 , 8] . Retinoids bind to retinoic acid receptors (RARs), which results in receptor heterodimerization and transcription of various genes in the nucleus [7] . As a result, specific DNA sequences are bound within the retinoid-responsive genes. It leads to activation or repression of genes, which are responsible for the regulation of cell growth, differentiation, and apoptosis [9 , 10] . The expression of retinoid receptors is not uniform in the human body. They are only present in the epidermis, hair follicles, sebaceous glands, or cells o","cbCaibxrqVOKxbh4","https://ap.wps.com/l/cbCaibxrqVOKxbh4","pdf",9999437,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What gap in knowledge does the study address about all-trans-retinal (ALTR) in breast cells?\",\"answer\":\"The work targets insufficient understanding of ALTR’s specific effects on breast cancer cell metabolism, particularly how dose and incubation time relate to tumor aggressiveness.\"},{\"question\":\"Which cell lines and experimental conditions were used to test ALTR?\",\"answer\":\"Non-tumorigenic MCF10A and malignant MCF7 and MDA-MB-231 cells were incubated with 1 and 10 µM ALTR for 24 and 48 hours.\"},{\"question\":\"How did the researchers assess metabolic and mitochondrial changes after ALTR treatment?\",\"answer\":\"Raman spectroscopy and imaging were used to detect qualitative and quantitative subcellular changes, while XTT assays measured biological viability; mitochondrial redox changes were inferred from cytochrome c band intensity changes.\"}]","All-trans-retinal as a modulator of metabolic and mitochondrial signatures in non-tumorigenic and malignant breast cells - a Ramanbased approach | PDF",1790166877,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3df75c0c49d1c3425729c47e9e1cea6d.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54ecd2d4c43dd81ad43e89ec243645cc.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/899b713891e4e3e3d910c9c508f04066.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0141f206ca54f233aff2ffa9b686d23.webp",980,1301]